News & Analysis on Clinical Trial Services & Contract Research And Development
Swiss life-science company Lonza announced on Tuesday that it is to strengthen the production of oligonucleotides - an emerging new class of therapeutics consisting of short nucleic acid chains interfering in the processing of genetic information.
In the second news of the day on a European life science company, DSM announced this week that from now on it will supply technologies and services for the initial development phases of new medicines - supplementing its existing service package of...
The US Food and Drug Administration announced this week that it has accomplished the initial objectives outlined in its ongoing initiative to modernise the agency's regulation of pharmaceutical manufacturing and product quality.
Women are becoming the most attractive target audience for healthcare companies, claims a new report from market analysts Datamonitor. A combination of increasing Internet access, a general interest in health issues among women along with high levels...